Enzo Biochem and Sequenom Inc. Partner to Market Key Sequenom Laboratories Prenatal Testing Service

NEW YORK--(BUSINESS WIRE)--The Enzo Clinical Labs subsidiary of Enzo Biochem, Inc. (NYSE:ENZ) has entered into an agreement to market in its northeast U.S. service area a proprietary early non-invasive prenatal laboratory test (“LDT”) service, MaterniT21 PLUS ™, developed by the Sequenom Laboratories, Inc., subsidiary of Sequenom, Inc. (NASDAQ:SQNM).

Help employers find you! Check out all the jobs and post your resume.